Davis MP - Search Results

1

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients.

Donskov F, Michaelson MD, Puzanov I, Davis MP, Bjarnason GA, Motzer RJ, Goldstein D, Lin X, Cohen DP, Wiltshire R, Rini BI. Donskov F, et al. Among authors: davis mp. Br J Cancer. 2015 Dec 1;113(11):1571-80. doi: 10.1038/bjc.2015.368. Epub 2015 Oct 22. Br J Cancer. 2015. PMID: 26492223 Free PMC article.

2

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma.

Cella D, Davis MP, Négrier S, Figlin RA, Michaelson MD, Bushmakin AG, Cappelleri JC, Sandin R, Korytowsky B, Charbonneau C, Matczak E, Motzer RJ. Cella D, et al. Among authors: davis mp. Cancer. 2014 Jun 15;120(12):1871-80. doi: 10.1002/cncr.28660. Epub 2014 Mar 13. Cancer. 2014. PMID: 24634003 Free PMC article. Clinical Trial.

3

Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.

Kollmannsberger C, Bjarnason G, Burnett P, Creel P, Davis M, Dawson N, Feldman D, George S, Hershman J, Lechner T, Potter A, Raymond E, Treister N, Wood L, Wu S, Bukowski R. Kollmannsberger C, et al. Oncologist. 2011;16(5):543-53. doi: 10.1634/theoncologist.2010-0263. Epub 2011 Apr 13. Oncologist. 2011. PMID: 21490127 Free PMC article. Review.

4

A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.

Kraut EH, Balcerzak SP, Young D, Davis MP, Jacobs SA; Ohio State University Phase II Reseeearch Consortium Study. Kraut EH, et al. Among authors: davis mp. Cancer Invest. 2002;20(2):174-9. doi: 10.1081/cnv-120001143. Cancer Invest. 2002. PMID: 11901536 Clinical Trial.

5

Epigenetic priming by hypomethylation enhances the immunogenic potential of tolinapant in T-cell lymphoma.

Ward GA, Zhang Z, Jueliger S, Potapov IS, Davis MP, Boxall AR, Taylor J, Keer H, Biondo A, Lyons JF, Sims M, Smyth T. Ward GA, et al. Among authors: davis mp. Cancer Res Commun. 2024 May 10. doi: 10.1158/2767-9764.CRC-23-0415. Online ahead of print. Cancer Res Commun. 2024. PMID: 38727208 Free article.

6

Conversion ratios: Why is it so challenging to construct opioid conversion tables?

Davis MP, McPherson ML, Reddy A, Case AA. Davis MP, et al. J Opioid Manag. 2024 Mar-Apr;20(2):169-179. doi: 10.5055/jom.0853. J Opioid Manag. 2024. PMID: 38700396 Review.

7

Spring applied phosphorus loss with cover crops in no-till terraced field.

Kaur H, Nelson KA, Singh G, Kaur G, Davis MP. Kaur H, et al. Among authors: davis mp. J Environ Manage. 2024 Mar;355:120431. doi: 10.1016/j.jenvman.2024.120431. Epub 2024 Mar 7. J Environ Manage. 2024. PMID: 38457890 Free article.

8

Letter to the Editor: The Surprise Question in Palliative Care: Does It Have a Role in Predicting Mortality?

Davis MP. Davis MP. J Palliat Med. 2024 Mar;27(3):292-293. doi: 10.1089/jpm.2023.0677. J Palliat Med. 2024. PMID: 38427904 No abstract available.

9

Missing Data and the Last Observation Carried Forward.

Davis MP. Davis MP. J Pain Symptom Manage. 2024 Jun;67(6):e921-e922. doi: 10.1016/j.jpainsymman.2024.02.019. Epub 2024 Feb 21. J Pain Symptom Manage. 2024. PMID: 38395094 No abstract available.

10

Radiation Therapy in the Last Month of Life: Association With Aggressive Care at the End of Life.

Davis MP, Vanenkevort E, Young A, Wojtowicz M, Gupta M, Lagerman B, Liu E, Mackley H, Panikkar R. Davis MP, et al. J Pain Symptom Manage. 2023 Dec;66(6):638-646. doi: 10.1016/j.jpainsymman.2023.08.024. Epub 2023 Aug 30. J Pain Symptom Manage. 2023. PMID: 37657725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page